News Quantified

LENZ – lenz therapeutics, inc. (US:NASDAQ)

Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors [Yahoo! Finance]

3/26

06:08 pm

lenz

Low

VUITY Reports Strong Market Performance, Setting New Benchmark in Presbyopia Care | DelveInsight [Yahoo! Finance]

LENZ Therapeutics, Inc. (NASDAQ: LENZ) had its price target raised by analysts at Citigroup Inc. from $44.00 to $47.00. They now have a "buy" rating on the stock.

LENZ Therapeutics, Inc. (LENZ) Q4 2024 Earnings Call Transcript [Seeking Alpha]

LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}